1-2 of 2
Philip M. Wade, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVd-lite) in Transplant-Ineligible Multiple Myeloma

Elizabeth K. O'Donnell, MD, Jacob P. Laubach, MD, Andrew J. Yee, MD, Robert Redd, Carol Ann Huff, MD, Frank Basile, MD, Philip M. Wade, MD, Claudia E. Paba-Prada, MD, Irene M. Ghobrial, MD, Robert L. Schlossman, MD, Jill N. Burke, NP, Cynthia C. Harrington, NP, Kathleen J. Lively, RN, Hannah Lyons, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Noopur S. Raje, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3178.
https://doi.org/10.1182/blood-2019-128000
Published: 2019
Journal Articles

A Phase II Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite) for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Elizabeth O'Donnell, MD, Jacob P. Laubach, MD, Andrew J Yee, MD, Carol Ann Huff, MD, Frank Basile, MD, Philip M. Wade, MD, Claudia E. Paba-Prada, MD, Irene M. Ghobrial, MD, Robert L Schlossman, MD, Nicole Couture, RN, Lauren Doherty, Hannah Lyons, RN, Caroline English, Nikhil Munshi, Kenneth C. Anderson, Paul G. Richardson, MD, Noopur Raje, MD
Journal: Blood
Blood (2014) 124 (21): 3454.
https://doi.org/10.1182/blood.V124.21.3454.3454
Published: 2014